A Comparison of the Real-Life Clinical Effectiveness of the Leading Licensed ICS/LABA Combination Inhalers in the Treatment for COPD

Wan Yau Ming, Simon; Haughney, John; Ryan, Dermot; Small, Iain; Lavorini, Federico; Papi, Alberto; Singh, Dave; Halpin, David; R. Hurst, John; Patel, Shishir; Ochel, Matthias; Kocks, Janwillem; Carter, Victoria; Hardjojo, Antony; Price, David

doi:10.2147/copd.s263745

Public

A Comparison of the Real-Life Clinical Effectiveness of the Leading Licensed ICS/LABA Combination Inhalers in the Treatment for COPD

Published in International Journal of COPD • Nov 1, 2020

Authors:

Simon Wan Yau Ming

John Haughney

Dermot Ryan

Abstract

Introduction: The Fostair® 100/6 (BDP/FF) pressurized metered-dose inhaler, delivering an extrafine formulation, is licensed for asthma and COPD in the UK. However, its real-life effectiveness for COPD has not been evaluated. This study compared the clinical effectiveness of BDP/FF against other lic...

Subject

Medicine

COPD

Internal medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!